Abiopharma

🔍 Thomas Corey E. (Director)

Company: Rapid7, Inc. (RPD)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 1,125,000 shares of PERFORMANCE RIGHTS (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,125,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: This security represents performance stock units ("PSUs") granted under the Issuer's 2015 Equity Incentive Plan, as amended, to the Reporting Person. Each PSU represents a contingent right to receive one share of common stock of the Issuer ("Common Stock").
• F2: The PSUs are eligible to vest upon the Issuer's Common Stock attaining specified stock price thresholds over a three-year performance period, subject to the Reporting Person's continued employment through the end of the performance period (except for certain good leaver events). The number of PSUs reflected is at the target number of PSUs, and the actual number of PSUs eligible to vest will range from 0% to 150% of the target number of PSUs.